Here are 8 key notes:
1. The company’s second quarter revenue was approximately $21.5 million, down slightly from pro forma revenue of around $21.6 million for the same period during 2015.
2. Consolidated net loss remained flat at $4.5 million in the second quarter of 2016.
3. Gross profit for the second quarter of 2016 was $14.7 million or 68.5 percent of revenue. During the second quarter of 2015, pro forma gross profit totaled $14 million or 64.9 percent of revenue.
4. Second quarter sales and marketing expenses increased to $10.4 million, up from $9.3 million during the same period last year.
5. General and administrative expenses decreased slightly from $4 million in the second quarter of 2015 to $3.9 million in the current quarter.
6. Core recurring revenue, which does not include revenue associated with original equipment manufacturer customers and other revenue, increased 5.6 percent to $20.9 million.
7. Xtant Medical’s consolidated EBITDA for the second quarter of 2016 was a gain of $332,973, compared to an EBITDA loss of $144,749 for the first quarter of 2016.
8. The company estimates full-year 2016 revenue to fall between $87 million and $90 million.
More articles on devices:
Paul Thomas newest addition to Cohera Medical’s board of directors: 5 highlights
Globus Medical to acquire Alphatec Holdings’ international business for $80M — 9 key insights
DeGen Medical’s F1 MPS Modular Pedicle Screw System for JOUST MIS procedure receives FDA approval: 4 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
